Clinical Edge Journal Scan

Clinical Edge Journal Scan

Second-line axi-cel therapy yields high response rates in high-risk relapsed or refractory LBCL

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

Commentary: Genetics, prognosis score, and PI3K in MCL, October 2023

Publish date: September 29, 2023

• Read More

Clinical Edge Journal Scan

Chemosensitivity helps predict survival outcomes after CAR T-cell therapy for DLBCL

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

Radiation therapy achieves effective palliation in MCL patients undergoing CAR T‐cell therapy

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

Past or active HBV infection associated with an increased risk for DLBCL

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

Bendamustine a safe alternative to fludarabine/cyclophosphamide lymphodepletion for axi-cel therapy in aggressive BCL

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

Concurrent MYC overexpression and TP53/p53 alterations indicative of poor prognosis in MCL

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

PI3Kδ inhibitor parsaclisib shows promise in relapsed or refractory follicular lymphoma

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

Tisagenlecleucel vs conventional treatment improves survival in DLBCL

Publish date: September 22, 2023

• Read More

Clinical Edge Journal Scan

CAR-HEMATOTOX score identifies patients at high risk for poor outcomes following brexu-cel infusion for MCL

Publish date: September 22, 2023

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• last »